Viracta Therapeutics Inc (VIRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0252 -0.0022 (-8.03%) 03/27/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0252 unch (unch) 15:47 ET
for Thu, Mar 27th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,058 | -49,197 | -114,762 | -19,017 | -23,330 |
| Depreciation Amortization | -1,562 | -416 | 178 | 32 | 46 |
| Accounts payable and accrued liabilities | -98 | -361 | 922 | 969 | -602 |
| Other Working Capital | 5,079 | 608 | 1,680 | 2,571 | -650 |
| Other Operating Activity | 7,747 | 13,909 | 93,131 | -609 | 2,351 |
| Operating Cash Flow | $-39,892 | $-35,457 | $-18,851 | $-16,054 | $-22,185 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,136 | -53,821 | N/A | N/A | N/A |
| PPE Investments | -138 | -45 | -252 | -55 | N/A |
| Net Acquisitions | N/A | N/A | 17,143 | N/A | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -20,035 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 3,750 |
| Purchase Sale Intangibles | N/A | N/A | -4,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -4,000 | 0 | 0 |
| Investing Cash Flow | $14,998 | $-53,866 | $12,891 | $-55 | $-16,285 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 19,986 | -234 | 5,260 | 5,453 |
| Common Stock Issued | 438 | 2,556 | 62,659 | 851 | 32,549 |
| Other Financing Activity | 0 | 0 | 0 | 38,869 | 5,033 |
| Financing Cash Flow | $438 | $22,542 | $62,425 | $44,980 | $43,035 |
| Beginning Cash Position | 36,773 | 103,554 | 47,089 | 18,218 | 13,696 |
| End Cash Position | 12,317 | 36,773 | 103,554 | 47,089 | 18,261 |
| Net Cash Flow | $-24,456 | $-66,781 | $56,465 | $28,871 | $4,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,892 | -35,457 | -18,851 | -16,054 | -22,185 |
| Capital Expenditure | -138 | -45 | -252 | -55 | N/A |
| Free Cash Flow | -40,030 | -35,502 | -19,103 | -16,109 | -22,185 |